Cargando…
Construction of immunotherapy-related prognostic gene signature and small molecule drug prediction for cutaneous melanoma
BACKGROUND: Cutaneous melanoma (CM), a kind of skin cancer with a high rate of advanced mortality, exhibits a wide variety of driver and transmitter gene alterations in the immunological tumor microenvironment (TME) associated with tumor cell survival and proliferation. METHODS: We analyzed the immu...
Autores principales: | Xing, Jiahua, Jia, Ziqi, Li, Yan, Han, Yan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9358033/ https://www.ncbi.nlm.nih.gov/pubmed/35957907 http://dx.doi.org/10.3389/fonc.2022.939385 |
Ejemplares similares
-
The Multi-Omics Landscape and Clinical Relevance of the Immunological Signature of Phagocytosis Regulators: Implications for Risk Classification and Frontline Therapies in Skin Cutaneous Melanoma
por: Xing, Jiahua, et al.
Publicado: (2022) -
Prognostic Implications of Metabolism Related Gene Signature in Cutaneous Melanoma
por: Zeng, Furong, et al.
Publicado: (2020) -
A novel inflammatory response-related signature predicts the prognosis of cutaneous melanoma and the effect of antitumor drugs
por: Xing, Jiahua, et al.
Publicado: (2022) -
Ferroptosis-related lncRNA signature predicts prognosis and immunotherapy efficacy in cutaneous melanoma
por: Xu, Yujian, et al.
Publicado: (2022) -
Mechanisms of Immunotherapy Resistance in Cutaneous Melanoma: Recognizing a Shapeshifter
por: Thornton, Jessica, et al.
Publicado: (2022)